• Title/Summary/Keyword: SK-302B

Search Result 3, Processing Time 0.017 seconds

In Vitro Chemosensitivity Test of SK-302B on Human Colon Carcinoma Cell Lines

  • Kim, Soo-Kie;Ahn, Chan-Mug;Kim, Tae-Ue;Choi, Sun-Ju;Park, Yoon-Sun;Shin, Woon-Seob;Koh, Choon-Myung
    • Archives of Pharmacal Research
    • /
    • v.19 no.4
    • /
    • pp.261-263
    • /
    • 1996
  • SK-302B, an antibiotic purified from soil Streptomyces sp. 302, was structurally identified as echinomycin (C/sub 50/H/sub 66/N/sub 11/S/sub 2/). In the present experiment, the possibility of SK-302B as an anticolon cancer agent was investigated by using chemosensitivity system (MTT assay, clonogenic assay). Treatment of SK-302B on various colon cancer cell lines resulted in a significant cytotoxicity and tumor colony formation inhibition. These studies showed that SK-302B had a potent inhibition on colon cancer cells.

  • PDF

Chip Equalizer using Tap Selection Algorithm for Satellite Digital Multimedia Broadcasting (DMB) (위성 DMB용 탭 선택적 칩 등화 수신기)

  • Lee Sang-Joon;Lee Goon-Seop;Lee Dong-Hahk;Yu Jae-Hwang;Seo Jong-Soo;Byeon Jeong-Ho
    • Journal of Broadcast Engineering
    • /
    • v.11 no.3 s.32
    • /
    • pp.302-310
    • /
    • 2006
  • ITU-R B.O. 1130-4 Digital System E adopted for Korean satellite DMB service is a multimedia broadcasting system based on DS-CDM-QPSK technique which broadcasts audio and video contents via the satellite or terrestrial gap-filler. However, Digital System E can not provide full loading services because the multi-channel interference (MCI) is increased due to the loss of orthogonality between signature waveforms in multipath fading channels. In this paper a chip equalizer using tap selection algorithm that enhances the receiving performance is proposed and compared to the conventional rake receiver for the satellite DMB system.

Differential Gene Expression Common to Acquired and Intrinsic Resistance to BRAF Inhibitor Revealed by RNA-Seq Analysis

  • Ahn, Jun-Ho;Hwang, Sung-Hee;Cho, Hyun-Soo;Lee, Michael
    • Biomolecules & Therapeutics
    • /
    • v.27 no.3
    • /
    • pp.302-310
    • /
    • 2019
  • Melanoma cells have been shown to respond to BRAF inhibitors; however, intrinsic and acquired resistance limits their clinical application. In this study, we performed RNA-Seq analysis with BRAF inhibitor-sensitive (A375P) and -resistant (A375P/Mdr with acquired resistance and SK-MEL-2 with intrinsic resistance) melanoma cell lines, to reveal the genes and pathways potentially involved in intrinsic and acquired resistance to BRAF inhibitors. A total of 546 differentially expressed genes (DEGs), including 239 up-regulated and 307 down-regulated genes, were identified in both intrinsic and acquired resistant cells. Gene ontology (GO) analysis revealed that the top 10 biological processes associated with these genes included angiogenesis, immune response, cell adhesion, antigen processing and presentation, extracellular matrix organization, osteoblast differentiation, collagen catabolic process, viral entry into host cell, cell migration, and positive regulation of protein kinase B signaling. In addition, using the PAN-THER GO classification system, we showed that the highest enriched GOs targeted by the 546 DEGs were responses to cellular processes (ontology: biological process), binding (ontology: molecular function), and cell subcellular localization (ontology: cellular component). Ingenuity pathway analysis (IPA) network analysis showed a network that was common to two BRAF inhibitorresistant cells. Taken together, the present study may provide a useful platform to further reveal biological processes associated with BRAF inhibitor resistance, and present areas for therapeutic tool development to overcome BRAF inhibitor resistance.